TickerFacts.

Incyte Corp (INCY): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$1.61B
Year ended 2025-12-31
$1.71B
Trailing 12 months to 2026-03-31
+35.4%
3-year compound annual growth
+32.6%
10-year compound annual growth
2009-12-31: -$123.08M2010-12-31: $38.53M2011-12-31: -$116.19M2012-12-31: $31.13M2013-12-31: $13.11M2014-12-31: $36.61M2015-12-31: $95.53M2016-12-31: $203.42M2017-12-31: -$191.21M2018-12-31: $184.19M2019-12-31: $456.54M2020-12-31: -$211.87M2021-12-31: $643.62M2022-12-31: $647.29M2023-12-31: $703.18M2024-12-31: $150.61M2025-12-31: $1.61B$1.61B
2009-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$1.61B+967.7%2026-02-10, From 2025-01-01
2024-12-31$150.61M-78.6%2026-02-10, From 2024-01-01
2023-12-31$703.18M+8.6%2026-02-10, From 2023-01-01
2022-12-31$647.29M+0.6%2025-02-10, From 2022-01-01
2021-12-31$643.62Mn/m2024-02-13, From 2021-01-01
2020-12-31-$211.87Mn/m2023-02-07, From 2020-01-01
2019-12-31$456.54M+147.9%2022-02-08, From 2019-01-01
2018-12-31$184.19Mn/m2021-02-09, From 2018-01-01
2017-12-31-$191.21Mn/m2020-02-13, From 2017-01-01
2016-12-31$203.42M+112.9%2019-02-14, From 2016-01-01
2015-12-31$95.53M+161.0%2018-02-15, From 2015-01-01
2014-12-31$36.61M+179.4%2017-02-14, From 2014-01-01
2013-12-31$13.11M-57.9%2016-02-12, From 2013-01-01
2012-12-31$31.13Mn/m2015-02-17, From 2012-01-01
2011-12-31-$116.19Mn/m2014-02-21, From 2011-01-01
2010-12-31$38.53Mn/m2013-02-21, From 2010-01-01
2009-12-31-$123.08Mn/a2012-02-22, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Incyte Corp (INCY)2025-12-31$1.61B+967.7%
Charles River Laboratories International, Inc. (CRL)2025-12-27$428.47M-27.3%
Icon PLC (ICLR)2025-12-31$825.84M-45.7%
Iqvia Holdings Inc. (IQV)2025-12-31$3.33B+0.3%
NRC Health (NRC)2025-12-31$30.21M-26.7%
MaxCyte, Inc. (MXCT)2025-12-31-$47.56Mn/m
OmniAb, Inc. (OABI)2025-12-31-$47.22Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$9.73Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.07Mn/m

Compare INCY, CRL, ICLR, IQV side by side · Screen every company in Services-Commercial Physical & Biological Research ↗